Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in... see more

TSXV:VPT - Post Discussion

VentriPoint Diagnostics Ltd > The Next Evolution in Health: see Ventripoint
View:
Post by jopatclo on Jun 12, 2024 10:05pm

The Next Evolution in Health: see Ventripoint

Join us on June 25 in downtown Vancouver for The Next Evolution in Health: Our AI & Health Data Opportunity. Explore how health data stewardship, AI, and life science research can revolutionize Canadian health services and elevate our global profile. Connect with top health and life science executives, researchers, and technology leaders.

The final agenda is complete — get your tickets now and be part of this transformative event. Check it out  https://lnkd.in/ePRnDS3N

Brought to you in collaboration with PwC Canada, Providence Health Care, Simon Fraser University, New York Institute of Technology - Vancouver & Ventripoint Diagnostics Ltd.

#buildthefuture #thedataeffect
Comment by jopatclo on Jun 12, 2024 10:42pm
Hugh MacNaught, President and CEO, Ventripoint Diagnostics Limited 1:00 PM Presentation: Will Hsiao, Faculty of Health Sciences, SFU & affiliated scientist at BC Centre for  Disease Control & Michael Smith Genome Sciences Centre ‍ 1:20 PM Panel : Accelerating AI Startups in Canadian Health Care  ...more  
VentriPoint Diagnostics Ltd
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities